SCHEMBL3949789

SCHEMBL3949789

CC(C)(C)OC(=O)NCCc1ccc(C(C)(C)C#N)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.50
▸ CA1 P00915 2/20 0.50
▸ NAMPT P43490 1/20 0.49
▸ ESRRG P62508 4/20 0.44
▸ CTSS P25774 2/20 0.44
▸ CTSK P43235 2/20 0.44
▸ ESRRB O95718 2/20 0.43
▸ MAPT P10636 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ NQO2 P16083 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PTGER4 P35408 1/20 0.41
▸ RORC P51449 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1067107 0.83 CA2 (0.52) CA2CA1NAMPTCTSSCTSK
SCHEMBL20208984 0.80 CTSS (0.50) CA2CA1NAMPTCTSSCTSK
SCHEMBL100146 0.80 KDM4E (0.60) CA2CA1NAMPTESRRGCTSS
SCHEMBL27741035 0.80 CA2 (0.56) CA2CA1NAMPTCTSKMAPT
SCHEMBL12283041 0.80 NPC1 (0.60) CA2CA1NAMPTMAPTTDP1
SCHEMBL1569661 0.80 CA2 (0.56) CA2CA1NAMPTCTSKMAPT
SCHEMBL8757517 0.79 CA2 (0.53) CA2CA1NAMPTMAPTTDP1
SCHEMBL23449213 0.79 CA2 (0.58) CA2CA1NAMPTCTSKMAPT
SCHEMBL13892916 0.79 CA2 (0.55) CA2CA1NAMPTCTSKMAPT
SCHEMBL21521028 0.79 CA2 (0.55) CA2CA1NAMPTCTSKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051967-A1 BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATMENT OF VALLINOID RECEPTOR TRPV1 RELATED DISORDERS AstraZeneca AB (SE) 2009-04-29 — — EP disclosed
WO-2008018827-A1 BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATMENT OF VALLINOID RECEPTOR TRPV1 RELATED DISORDERS ASTRAZENECA AB (SE) 2008-02-14 — — WO disclosed
Send feedback